First Time Loading...

EyePoint Pharmaceuticals Inc
NASDAQ:EYPT

Watchlist Manager
EyePoint Pharmaceuticals Inc Logo
EyePoint Pharmaceuticals Inc
NASDAQ:EYPT
Watchlist
Price: 11.13 USD -0.27% Market Closed
Updated: May 29, 2024

EyePoint Pharmaceuticals Inc
Accounts Payable

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

EyePoint Pharmaceuticals Inc
Accounts Payable Peer Comparison

Comparables:
JNJ
BMY
PFE
MRK
LLY

Competitive Accounts Payable Analysis
Latest Figures & CAGR of Competitors

Company Accounts Payable CAGR 3Y CAGR 5Y CAGR 10Y
EyePoint Pharmaceuticals Inc
NASDAQ:EYPT
Accounts Payable
$7.1m
CAGR 3-Years
6%
CAGR 5-Years
2%
CAGR 10-Years
24%
Johnson & Johnson
NYSE:JNJ
Accounts Payable
$8.2B
CAGR 3-Years
-1%
CAGR 5-Years
3%
CAGR 10-Years
3%
Bristol-Myers Squibb Co
NYSE:BMY
Accounts Payable
$3.5B
CAGR 3-Years
6%
CAGR 5-Years
12%
CAGR 10-Years
4%
Pfizer Inc
NYSE:PFE
Accounts Payable
$5.6B
CAGR 3-Years
11%
CAGR 5-Years
6%
CAGR 10-Years
8%
Merck & Co Inc
NYSE:MRK
Accounts Payable
$3.5B
CAGR 3-Years
-4%
CAGR 5-Years
3%
CAGR 10-Years
4%
Eli Lilly and Co
NYSE:LLY
Accounts Payable
$2.5B
CAGR 3-Years
15%
CAGR 5-Years
16%
CAGR 10-Years
8%

See Also

What is EyePoint Pharmaceuticals Inc's Accounts Payable?
Accounts Payable
7.1m USD

Based on the financial report for Mar 31, 2024, EyePoint Pharmaceuticals Inc's Accounts Payable amounts to 7.1m USD.

What is EyePoint Pharmaceuticals Inc's Accounts Payable growth rate?
Accounts Payable CAGR 10Y
24%

Over the last year, the Accounts Payable growth was -25%. The average annual Accounts Payable growth rates for EyePoint Pharmaceuticals Inc have been 6% over the past three years , 2% over the past five years , and 24% over the past ten years .